Drug Deals Tie Prices to How Well Patients Do
Pay-for-Performance comes to Pharma. The article talks about a deal between Merck and Cigna that ties drug prices to outcomes. It's an interesting idea to tie reimbursements to effectiveness and compliance, but it cuts physicians out of the decision-making process. It also threatens to make the most effective drugs more expensive, making care for the uninsured more unattainable.
Democrats Consider Bypassing G.O.P. on Health Care Plan: Democrats are tempted to use their political muscle to speed passage of health care legislation with minimal concessions to the Republican minority.
As always, please feel free to contact me with any questions or concerns, or to discuss any of these issues.
Regards,
Erick Eiting, MD, MPH
Pay-for-Performance comes to Pharma. The article talks about a deal between Merck and Cigna that ties drug prices to outcomes. It's an interesting idea to tie reimbursements to effectiveness and compliance, but it cuts physicians out of the decision-making process. It also threatens to make the most effective drugs more expensive, making care for the uninsured more unattainable.
Democrats Consider Bypassing G.O.P. on Health Care Plan: Democrats are tempted to use their political muscle to speed passage of health care legislation with minimal concessions to the Republican minority.
As always, please feel free to contact me with any questions or concerns, or to discuss any of these issues.
Regards,
Erick Eiting, MD, MPH
No comments:
Post a Comment